Deal Snapshot
Infectious Disease Connect Combines with US Merck´s ILÚM Health Solutions
Wednesday 20 May 2020

US-based drugmaker Merck's (NYSE: MRK) ILÚM Health Solutions has combined with Infectious Disease Connect Inc., a University of Pittsburgh Medical Center-backed company offering telemedicine-enabled solutions to hospitals for treatment of infectious diseases, to support infectious disease management, clinical decision-support and precision antibiotic therapy, Merck said.

As part of this agreement, UPMC Enterprises, the innovation and commercialisation arm of UPMC, and Merck Global Health Innovation Fund each are investing USD 5m to support development of customer offerings and business growth for the newly combined entity.

Date Published: 20/05/2020